One in ten Danes live with a mental illness, and one in three will receive a psychiatric diagnosis during their lifetime.
Mental illness can arise from many different causes, including biological, social and psychological factors. It encompasses a wide range of conditions, including schizophrenia, affective disorders, anxiety disorders, substance use disorders, dementia, ADHD, autism spectrum disorders, and personality disorders, each with distinct causes, manifestations and outcomes.
People living with mental illness often have a weaker attachment to the labour market, a higher prevalence of a range of physical illnesses and typically have a life expectancy that is 7 to 20 years shorter than that of the general population. This excess mortality is partly due to suicide and partly to physical diseases, such as cancer and diabetes. There are also substantial social inequalities in both the prevalence of mental illness and its consequences.
Our research integrates epidemiology, psychiatry, and social medicine, contributing to a better understanding of the mechanisms underlying mental illness. Focus areas include affective disorders, dementia, alcohol use disorders and sleep.
We also investigate the need for and use of medications and other treatments, treatment resistance and the effects of treatments such as antipsychotic and antidepressant medications, including electroconvulsive therapy (ECT). The overall aim is to improve prevention and treatment.
We primarily conduct register-based studies, taking advantage of Denmark's unique opportunities to combine nationwide registry data on health, socioeconomic factors such as education, income and employment, and medication use, including both medicines administered in hospitals and prescriptions dispensed through pharmacies. We also study other forms of treatment, including psychotherapy and ECT.
In addition, we use data from population surveys and patient health records and participate in intervention studies aimed at preventing the development of mental illness and improving treatment outcomes.
We work closely with the fields of psychiatry and social medicine and provide knowledge and expertise to psychiatric departments, national and international research groups, private companies, advocacy organizations, and professional societies.